Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Veber

Showing results (91-100 of 100) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 100 results.
Journal of Medicinal Chemistry|October 28, 2005
Azepanone-based inhibitors of human cathepsin LRobert W Marquis, Ian James, Jin Zeng, et al.
Bioorganic & Medicinal Chemistry|June 3, 1999
Potent dipeptidylketone inhibitors of the cysteine protease cathepsin KR W Marquis, Y Ru, D S Yamashita, et al.
Journal of Medicinal Chemistry|March 23, 2001
Cyclic ketone inhibitors of the cysteine protease cathepsin KR W Marquis, Y Ru, J Zeng, et al.
Life Sciences|January 1, 1996
Pharmacology of L-744,453, a novel nonpeptidyl endothelin antagonistD L Williams, K L Murphy, N A Nolan, et al.
Journal of Medicinal Chemistry|November 24, 2011
Optimization of the potency and pharmacokinetic properties of a macrocyclic ghrelin receptor agonist (Part I): Development of ulimorelin (TZP-101) from hit to clinicHamid R Hoveyda, Eric Marsault, René Gagnon, et al.
Journal of Medicinal Chemistry|July 20, 2007
Highly potent inhibitors of methionine aminopeptidase-2 based on a 1,2,4-triazole pharmacophoreJoseph P Marino, Paul W Fisher, Glenn A Hofmann, et al.
Journal of Medicinal Chemistry|September 2, 2005
4-Aryl-1,2,3-triazole: a novel template for a reversible methionine aminopeptidase 2 inhibitor, optimized to inhibit angiogenesis in vivoLara S Kallander, Qing Lu, Wenfang Chen, et al.
Journal of Medicinal Chemistry|March 3, 2006
Structure activity relationships of 5-, 6-, and 7-methyl-substituted azepan-3-one cathepsin K inhibitorsDennis S Yamashita, Robert W Marquis, Ren Xie, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 1998
Design of potent and selective human cathepsin K inhibitors that span the active siteS K Thompson, S M Halbert, M J Bossard, et al.
Journal of Medicinal Chemistry|April 20, 2001
Azepanone-based inhibitors of human and rat cathepsin KR W Marquis, Y Ru, S M LoCastro, et al.
Pageof 10

Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
Journal of Medicinal Chemistry|October 28, 2005
Azepanone-based inhibitors of human cathepsin LRobert W Marquis, Ian James, Jin Zeng, et al.
Bioorganic & Medicinal Chemistry|June 3, 1999
Potent dipeptidylketone inhibitors of the cysteine protease cathepsin KR W Marquis, Y Ru, D S Yamashita, et al.
Journal of Medicinal Chemistry|March 23, 2001
Cyclic ketone inhibitors of the cysteine protease cathepsin KR W Marquis, Y Ru, J Zeng, et al.
Life Sciences|January 1, 1996
Pharmacology of L-744,453, a novel nonpeptidyl endothelin antagonistD L Williams, K L Murphy, N A Nolan, et al.
Journal of Medicinal Chemistry|November 24, 2011
Optimization of the potency and pharmacokinetic properties of a macrocyclic ghrelin receptor agonist (Part I): Development of ulimorelin (TZP-101) from hit to clinicHamid R Hoveyda, Eric Marsault, René Gagnon, et al.
Journal of Medicinal Chemistry|July 20, 2007
Highly potent inhibitors of methionine aminopeptidase-2 based on a 1,2,4-triazole pharmacophoreJoseph P Marino, Paul W Fisher, Glenn A Hofmann, et al.
Journal of Medicinal Chemistry|September 2, 2005
4-Aryl-1,2,3-triazole: a novel template for a reversible methionine aminopeptidase 2 inhibitor, optimized to inhibit angiogenesis in vivoLara S Kallander, Qing Lu, Wenfang Chen, et al.
Journal of Medicinal Chemistry|March 3, 2006
Structure activity relationships of 5-, 6-, and 7-methyl-substituted azepan-3-one cathepsin K inhibitorsDennis S Yamashita, Robert W Marquis, Ren Xie, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 1998
Design of potent and selective human cathepsin K inhibitors that span the active siteS K Thompson, S M Halbert, M J Bossard, et al.
Journal of Medicinal Chemistry|April 20, 2001
Azepanone-based inhibitors of human and rat cathepsin KR W Marquis, Y Ru, S M LoCastro, et al.
Pageof 10